Circulating microRNAs as mirrors of acute coronary syndromes: MiRacle or quagMire?

Journal of Cellular and Molecular Medicine

Jin Li²  Jiahong Xu⁴  Yan Cheng³  Fei Wang¹  Yang Song¹ 

[1] Division of Gastroenterology and Hepatology, Digestive Disease Institute, Tongji Hospital, Tongji University School of Medicine, Shanghai, China;Regeneration Lab, School of Life Science, Shanghai University, Shanghai, China;Department of Psychiatry, Tongji University School of Medicine, Shanghai, China;Department of Cardiology, Tongji Hospital, Tongji University School of Medicine, Shanghai, China

关键词: microRNA;    plasma;    serum;    biomarker;    acute coronary syndromes;   

DOI  :  10.1111/jcmm.12148

来源: Wiley

【 摘 要 】

Abstract

Acute coronary syndrome (ACS), a leading cause of morbidity and mortality worldwide, is among the most serious cardiovascular diseases. Exploring novel approaches, which can complement and improve current strategies for ACS, is continuous. MicroRNAs (miRNAs) are a novel class of small, short non-coding RNA that post-transcriptionally regulate genes. The tissue- or cell-specific distribution features of miRNAs and its merit of stably existing in serum and plasma make them attractive biomarkers for ACS. An early and accurate diagnosis is the pre-requisite to facilitate rapid decision making and treatment and therefore improve outcome in ACS patients. This review highlights and summarizes recent studies using circulating miRNAs as novel biomarkers for ACS including its role in diagnosis, prediction, prognosis and reaction to therapy. In addition, we also discuss the potential function of miRNAs as extracellular communicators in cell-to-cell communication. Large multicentre studies are highly needed to pave the road for using circulating miRNAs as biomarkers for ACS from the bench to the bedside. Considering the advantageous properties and the continuously increasing number of studies, circulating miRNAs definitely have the potential to be reasonable diagnostic tools once their infancy has passed.

【 授权许可】

CC BY   
© 2013 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.

Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.